[Treatment of parkinsonian states with L-dopa].
D000547:Amantadine / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine; D000547:Amantadine
Traitement des états parkinsoniens par la L-dopa.